title: The new lipid guidelines: what do primary care clinicians think?
abstract: BACKGROUND
  Little is known about the opinions of primary care clinicians regarding the newly released 2013 American College of Cardiology/American Heart Association (ACC/AHA) Guidelines for the Prevention of Primary and Secondary Atherosclerotic Disease. This survey was created to assess the awareness, attitudes, and practices of primary care clinicians on adoption of the new guidelines and to explore obstacles to implementation and suggestions for improving shared decision-making.
  
  
  METHODS
  Six hundred practicing clinicians within the San Francisco Bay Area Collaborative Research Network were invited to participate in this cross-sectional, Internet-based pilot survey of primary care clinicians. These survey data were collected in March 2014, approximately 4 months after the release of the new guidelines and 1 month after the release of the ACC/AHA risk estimator application.
  
  
  RESULTS
  One hundred eighty-three clinicians responded to the survey. Of those respondents, 176 (96%) were aware of the guidelines. The majority (64%) reported implementing the new guidelines with at least some of their patients, while a minority (25%) reported adopting the guidelines for many of their patients. Disagreeing with the guidelines was the main hindrance to adoption.
  
  
  CONCLUSIONS
  While many primary care clinicians are aware of the new guidelines, a substantial proportion has yet to implement them into their clinical practice, and obstacles remain for full adoption. Further understanding of clinicians' views, opinions, and needs is necessary to optimize the approach to lipid management and ensure integration into current practice.
authors.affiliation: Department of Medicine, University of California, San Francisco (UCSF), San Francisco.
authors.forename: Sina
authors.initials: S
authors.lastname: Jamé
authors.affiliation: Center for Health Decision Science, Harvard School of Public Health, Boston, Mass.
authors.forename: Eve
authors.initials: E
authors.lastname: Wittenberg
authors.affiliation: Department of Family and Community Medicine, UCSF, San Francisco.
authors.forename: Michael B
authors.initials: MB
authors.lastname: Potter
authors.affiliation: Department of Medicine, University of California, San Francisco (UCSF), San Francisco; Division of Cardiology, Department of Medicine, UCSF, San Francisco. Electronic address: fleischm@medicine.ucsf.edu.
authors.forename: Kirsten E
authors.initials: KE
authors.lastname: Fleischmann
mesh_terms: D000328:Adult; D000368:Aged; D000572:American Heart Association; D003324:Coronary Artery Disease / Q000517:prevention & control*; D003430:Cross-Sectional Studies; D005260:Female; D019983:Guideline Adherence; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D058007:Physicians, Primary Care; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D014481:United States; D055815:Young Adult
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors
keywords: AHA/ACC guidelines; Cholesterol; Primary care providers
references.citation: Lancet. 2013 Nov 30;382(9907):1762-5
references.pmid: 24268611
references.citation: JAMA. 2014 Feb 5;311(5):463-4
references.pmid: 24296612
references.citation: N Engl J Med. 2014 Apr 10;370(15):1422-31
references.pmid: 24645848
references.citation: JAMA. 2014 Apr 9;311(14):1416-23
references.pmid: 24681960
references.citation: Circulation. 2014 Jun 17;129(24):2539-2546
references.pmid: 24744274
references.citation: JAMA. 2014 Apr 9;311(14):1406-15
references.pmid: 24682252
references.citation: JAMA Intern Med. 2013 Jan 14;173(1):38-43
references.pmid: 23403978
references.citation: Lancet. 2014 Feb 15;383(9917):600-2
references.pmid: 24315619